IBT
PCRX icon

International Biotechnology Trust’s Pacira BioSciences PCRX Stock Holding History

International Biotechnology Trust’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,000
Closed -$762K – 61
2017
Q2 		$762K Hold
16,000
– – 0.29% 54
2017
Q1 		$729K Buy
+16,000
New +$692K 0.28% 56

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

International Biotechnology Trust's PCRX Position: Q3 2017 in Review

International Biotechnology Trust sold out of Pacira BioSciences (PCRX) in Q3 2017, closing a stake of 16,000 shares — an estimated $762K sold.

International Biotechnology Trust first reported a position in PCRX in Q1 2017 and held it in 2 quarters. The position peaked at $762K in Q2 2017. 180 funds tracked by Wall St. Rank hold PCRX as of Q3 2017.

  • International Biotechnology Trust reported no remaining Pacira BioSciences position as of Q3 2017 after selling out during the quarter.
  • International Biotechnology Trust sold 16,000 Pacira BioSciences shares in Q3 2017, an estimated $762K.
  • International Biotechnology Trust first reported a position in Pacira BioSciences in Q1 2017 and held it in 2 quarters.
  • International Biotechnology Trust's Pacira BioSciences position peaked at $762K in Q2 2017.
  • 180 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2017.

Based on International Biotechnology Trust's 13F filing for Q3 2017, filed 2 Mar 2018.